/

Empresas

Ju

No verificado

Judo Bio

Sobre qué escribimos

BiotecnologíaEventosFarmacéuticaIndustriaSalud

4 Comunicados de prensa

Ver todos los comunicados de prensa

26/10/2024

Eventos

Biotecnología

Salud

Farmacéutica

Medicina - Varios

Judo Bio Presents Data Demonstrating Mechanism of Receptor-mediated Delivery of Oligonucleotides Resulting in Gene Silencing in the Kidney

Fuente

Editor

1.00

0

11/10/2024

Eventos

Ferias y Congresos

Biotecnología

Farmacéutica

Salud

Judo Bio to Present Data at the ASN Kidney Week 2024 Demonstrating Receptor‑mediated Delivery of Oligonucleotides to the Kidney

Fuente

Editor

1.00

0

07/10/2024

Biotecnología

Farmacéutica

Salud

Eventos

Industria

Judo Bio Unveils Data Demonstrating Receptor-mediated Delivery of Oligonucleotides to the Kidney

Fuente

Editor

1.00

0

07/10/2024

Mercado laboral

Salud

Biotecnología

Ciencia

Farmacéutica

Judo Bio Launches with $100 Million Financing to Develop Oligonucleotide Therapies Delivered to the Kidney and Appoints Rajiv Patni as CEO

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0